Guanfacine 2 TAKEDA, guanfacine (as hydrochloride) 2 mg modified release tablet blister pack

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

guanfacine hydrochloride, Quantity: 2.28 mg

Boleh didapati daripada:

Takeda Pharmaceuticals Australia Pty Ltd

Borang farmaseutikal:

Tablet, modified release

Komposisi:

Excipient Ingredients: hypromellose; methacrylic acid - ethyl acrylate copolymer (1:1); sodium lauryl sulfate; polysorbate 80; microcrystalline cellulose; colloidal anhydrous silica; lactose; povidone; crospovidone; glycerol dibehenate; fumaric acid

Laluan pentadbiran:

Oral

Unit dalam pakej:

7, 28

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6-17 years old, as monotherapy (when stimulants or atomoxetine are not suitable, not tolerated or have been shown to be ineffective) or as adjunctive therapy to psychostimulants (where there has been a sub-optimal response to psychostimulants). must be used as part of a comprehensive ADHD management programme, typically including psychological, educational and social measures.

Ringkasan produk:

Visual Identification: Oblong, white to off-white tablets and debossed with '2MG' on one side and '503' on the other side.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status kebenaran:

Registered

Tarikh kebenaran:

2022-12-02